MedPath
HSA Approval

PAXIMOL 250 ORAL MIXTURE 250 mg/5 ml

SIN09240P

PAXIMOL 250 ORAL MIXTURE 250 mg/5 ml

PAXIMOL 250 ORAL MIXTURE 250 mg/5 ml

March 7, 1997

ICM PHARMA PTE. LTD.

ICM PHARMA PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantICM PHARMA PTE. LTD.
Licence HolderICM PHARMA PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

SUSPENSION

ORAL

Medical Information

N02BE01

paracetamol

Manufacturer Information

ICM PHARMA PTE. LTD.

ICM PHARMA PTE. LTD.

Active Ingredients

PARACETAMOL

250 mg/5 ml

Acetaminophen

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PAXIMOL 250 ORAL MIXTURE 250 mg/5 ml - HSA Approval | MedPath